Table 2.
Alive | Died | P | |
---|---|---|---|
N = 65 | N = 42 | ||
Age* (years) | 68 (11) | 70 (10) | 0.35 |
BMI* (kg/m2) | 24.5 (4.2) | 25.4 (4.0) | 0.31 |
Female | 92% (60) | 78.5% (33) | 0.04 |
Male | 8% (5) | 21% (9) | |
HR > 90 bpm | 31% (20) | 41% (17) | 0.36 |
RR systolic < 90 mmHg | 3% (2) | 12% (5) | 0.10 |
HR > 90 bpm & RR systolic < 90 mmHg | 2% (1) | 7% (3) | 0.17 |
Laboratory Measurements | |||
Troponin I (ng/ml) admission* | 2.18 (3.78) | 2.39 (5.16) | 0.81 |
Troponin I (ng/ml) maximum* | 6.19 (12.90) | 9.94 (23.35) | 0.30 |
Creatinkinase (U/l) on admission * | 206 (187) | 452(833) | 0.025 |
Creatin (U/l) maximum * | 421 (745) | 930 (1816) | 0.049 |
Hemoglobin (g/dl) * | 13.5 (1.4) | 12.4 (2.1) | 0.04 |
|
11% (7) | 38% (16) | <0.001 |
Leukocytes | 10.3 (5.3) | 12.3 (6.4) | 0.09 |
Echocardiography | |||
EF on admission* (%) | 36 (10) | 31 (12) | 0.45 |
EF prior discharge* (%) | 46 (11) | 41 (9) | 0.06 |
Laevocardiography | |||
EF angio (%) | 36 (12) | 34 (13) | 0.21 |
Typical contraction pattern | 66 (43) | 79 (33) | 0.17 |
Indication for angiography | 0.004 | ||
|
19% (12) | 21% (9) | |
|
62% (40) | 38% (16) | |
|
11% (7) | 14% (6) | |
|
9% (6) | 7% (3) | |
|
0% (0) | 18% (8) | |
Identifyable trigger | 57% (37) | 74% (31) | 0.08 |
|
15% (10) | 10% (4) | 0.07 |
|
42% (27) | 64% (27) | |
Carcinoma | 2% (1) | 14% (6) | 0.009 |
Re-TTS | 11% (7) | 7% (3) | 0.53 |
*Mean (standard deviation); BMI, body mass index; HR, heart rate; RR, blood pressure; EF, ejection fraction; STEMI, st-segment elevation myocardial infarction; NSTEMI, non-st-segment elevation myocardial infarction; AP, angina pectoris; TTS, tako-tsubo-syndrome.